British Journal of Haematology · 1995 · 27 citations · 18 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacotherapySepsisTransplant ImmunologyAntifungal AgentsAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsFungal PathogenesisTransplant Infectious ComplicationsAmphotericin B NephrotoxicityAspergillosis TherapyFungal Infection TreatmentFungal Infections In Immunocompromised HostsFungal Infections In Transplant RecipientsInfections After TransplantationRenal Adverse EffectsTransplant Complications Management
60 patients undergoing bone marrow or stem cell transplantation were treated with liposomal Amphotericin-B for documented or suspected mycosis. 34 patients had a prior course of conventional Amphotericin-B with the following adverse effects: increasing creatinine above 1.4 mg/dl (n = 17), increasing creatinine below 1.5 mg/dl (n = 9), no response (n = 6), and clinical side-effects (n = 4). Liposomal Amphotericin-B failed in 6/7 patients with culture-proven mycosis who died from infection with Aspergillus (n = 2) and Candida (n = 4), respectively. One patient with Candida lambica sepsis was cured. No patient with clinically or serologically suspected or diagnosed infection died from mycosis. Liposomal Amphotericin-B was well tolerated in 57 patients, even after side-effects of the conventional formulation. Adverse effects occurred in three cases, requiring the withdrawal of the drug in one patient. Due to toxic side-effects of the high-dose therapy and transplant-related complications, it was difficult to evaluate the influence of liposomal Amphotericin-B on laboratory parameters. Eight patients showed a decrease of creatinine levels, which had increased above normal values under preceding therapy with conventional Amphotericin-B. Liposomal Amphotericin-B is well tolerated in patients undergoing high-dose therapy and bone marrow transplantation. The efficacy of liposomal Amphotericin-B needs to be investigated in randomized studies in comparison with conventional Amphotericin-B.
18
John R. Wingard, William G. Merz, Michael G. Rinaldi et al. · New England Journal of Medicine · 1991 · 947 citations
Regimen-related toxicity in patients undergoing bone marrow transplantation.
Scott I. Bearman, F R Appelbaum, CD Buckner et al. · Journal of Clinical Oncology · 1988 · 878 citations
Medicine, Oncology, Chemotherapy +16
Nephrotoxicity of Amphotericin B
William T. Butler · Annals of Internal Medicine · 1964 · 330 citations
Treatment of systemic fungal infections with liposomal amphotericin B.
G Lopez-Berestein, Gerald P. Bodey, Victor Fainstein et al. · PubMed · 1989 · 177 citations
Wendy Mills, Rajesh Chopra, David C. Linch et al. · British Journal of Haematology · 1994 · 172 citations